Novo Nordisk | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
ANI Pharmaceuticals USD -13762000 17.74M 2024-12
Aurora Cannabis CAD 32.07M 31.47M 2024-12
Bausch Health Companies USD -21000000 69M 2024-09
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Canopy Growth CAD -121580000 9.67M 2024-12
Corcept Therapeutics USD 161.49M 108.55M 2024-12
Drreddys Laboratories 18.74B 431M 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
Merck USD 5.22B 114M 2024-12
Novartis USD 4.66B 269M 2024-12
Novo Nordisk 34.38B 9.05B 2024-09
Novo Nordisk DKK 34.38B 9.05B 2024-09
Pacira USD 49.58M 8.89M 2024-09
Perrigo USD 151.3M 11.9M 2024-12
Prestige Brands USD 80.15M 8.49M 2024-12
Sanofi EUR 2.18B 1.33B 2024-12
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12
Zoetis USD 773M 144M 2024-12



Novo Nordisk L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.